Abstract:
Objective A study was conducted to determine the expression of acetyl-coa carboxylase product of phosphorylation (P-ACC) and an enzyme called cyclooxygenase 2 (COX-2) in non-small cell lung cancer (NSCLC) tissue, as well as the relationship and correlations between tumor size, lymph node metastasis, clinical stage, and pathological type.
Methods Sixty-two patients with NSCLC lung cancer tissues were included in the patient group, whereas 20 patients who underwent lobectomy for other reasons and had normal lung tissues were included in the control group. Immunohistochemical streptavidin peroxidase method was used to detect the expression of P-ACC and COX-2 in lung cancer and normal lung tissues.
Results The positive expressions of P-ACC and COX-2 in NSCLC lung cancer and normal lung tissues were significantly different (P < 0.05). In NSCLC tissues, the positive expression of P-ACC was significantly associated with tumor size (P < 0.05), but was not significantly associated with lymph node metastasis, clinical stage, and pathological type. We found no correlation between the positive expression of COX-2 and tumor size, lymph node metastasis, clinical stage and pathological type. Further analysis revealed that the positive expression of P-ACC and COX-2 in NSCLC was significantly and negatively correlated (r=-2.37, P=0.032).
Conclusion The positive expression of COX-2 in NSCLC greatly increased compared with that of P-ACC, and a significantly negative correlation was observed between them. We propose that the positive expression of P-ACC reduction may activate the positive expression of COX-2 and promote the occurrence, development, invasion, and metastasis of NSCLC.